| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7680690
[patent_doc_number] => 20100105896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'PHARMACEUTICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/645415
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16048
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105896.pdf
[firstpage_image] =>[orig_patent_app_number] => 12645415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/645415 | Pharmaceutical compounds | Dec 21, 2009 | Issued |
Array
(
[id] => 6616564
[patent_doc_number] => 20100099722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => '2-(BENZIMIDAZOL-1-YL)-N-(4-PHENYLTHIAZOL-2-YL) ACETAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/643363
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4460
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099722.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643363 | 2-(BENZIMIDAZOL-1-YL)-N-(4-PHENYLTHIAZOL-2-YL) ACETAMIDE DERIVATIVES | Dec 20, 2009 | Abandoned |
Array
(
[id] => 7801269
[patent_doc_number] => 08129541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => '5-phenylthiazole derivatives and use as PI3 kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/640479
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27445
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129541.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640479 | 5-phenylthiazole derivatives and use as PI3 kinase inhibitors | Dec 16, 2009 | Issued |
Array
(
[id] => 6401520
[patent_doc_number] => 20100179147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/635206
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14865
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635206
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635206 | Benzimidazole compounds and their use as anticancer agents | Dec 9, 2009 | Issued |
Array
(
[id] => 7527621
[patent_doc_number] => 08044213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Thiazolyl-benzimidazoles'
[patent_app_type] => utility
[patent_app_number] => 12/634771
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31666
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12634771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/634771 | Thiazolyl-benzimidazoles | Dec 9, 2009 | Issued |
Array
(
[id] => 7680672
[patent_doc_number] => 20100105914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'CASPASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/630350
[patent_app_country] => US
[patent_app_date] => 2009-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33749
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105914.pdf
[firstpage_image] =>[orig_patent_app_number] => 12630350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/630350 | CASPASE INHIBITORS AND USES THEREOF | Dec 2, 2009 | Abandoned |
Array
(
[id] => 7742224
[patent_doc_number] => 20120020950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'ANTIBACTERIAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/131469
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19158
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020950.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131469
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131469 | Antibacterial compounds | Nov 30, 2009 | Issued |
Array
(
[id] => 8944202
[patent_doc_number] => 08497382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => 'Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/132292
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19044
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132292
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132292 | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof | Nov 30, 2009 | Issued |
Array
(
[id] => 8375519
[patent_doc_number] => 08258311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Human protein tyrosine phosphatase inhibitors and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/624072
[patent_app_country] => US
[patent_app_date] => 2009-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26014
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624072 | Human protein tyrosine phosphatase inhibitors and methods of use | Nov 22, 2009 | Issued |
Array
(
[id] => 7696109
[patent_doc_number] => 20110230481
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2011-09-22
[patent_title] => 'DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOD OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/617067
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16081
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0230/20110230481.pdf
[firstpage_image] =>[orig_patent_app_number] => 12617067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617067 | DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOD OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT | Nov 11, 2009 | Abandoned |
Array
(
[id] => 7696109
[patent_doc_number] => 20110230481
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2011-09-22
[patent_title] => 'DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOD OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/617067
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16081
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0230/20110230481.pdf
[firstpage_image] =>[orig_patent_app_number] => 12617067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617067 | DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOF OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT | Nov 11, 2009 | Abandoned |
Array
(
[id] => 9552488
[patent_doc_number] => 08759539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Substituted bicyclic amines for the treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/125088
[patent_app_country] => US
[patent_app_date] => 2009-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13292
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125088 | Substituted bicyclic amines for the treatment of diabetes | Nov 10, 2009 | Issued |
Array
(
[id] => 9047041
[patent_doc_number] => 08541595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Imidazoisoindole neuropeptide S receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/127985
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25763
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127985
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127985 | Imidazoisoindole neuropeptide S receptor antagonists | Nov 2, 2009 | Issued |
Array
(
[id] => 6595527
[patent_doc_number] => 20100048565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'BENZIMIDAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/607931
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26286
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048565.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607931 | BENZIMIDAZOLE DERIVATIVES | Oct 27, 2009 | Abandoned |
Array
(
[id] => 9216484
[patent_doc_number] => 08629284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 13/129063
[patent_app_country] => US
[patent_app_date] => 2009-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20950
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129063
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129063 | Chemical compounds | Oct 26, 2009 | Issued |
| 12/605666 | PROTECTED FORMS OF PHARMACOLOGICALLY ACTIVE AGENTS AND USES THEREFOR | Oct 25, 2009 | Abandoned |
Array
(
[id] => 8555443
[patent_doc_number] => 08329914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Cyclic benzimidazole derivatives useful as anti-diabetic agents'
[patent_app_type] => utility
[patent_app_number] => 13/125345
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50816
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125345
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125345 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Oct 21, 2009 | Issued |
Array
(
[id] => 8932853
[patent_doc_number] => 08492555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester'
[patent_app_type] => utility
[patent_app_number] => 13/125443
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 14853
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125443
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125443 | Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester | Oct 20, 2009 | Issued |
Array
(
[id] => 8538532
[patent_doc_number] => 08314253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Bridged tetrahydronaphthalene derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/125424
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16365
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125424 | Bridged tetrahydronaphthalene derivatives | Oct 20, 2009 | Issued |
Array
(
[id] => 8932853
[patent_doc_number] => 08492555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester'
[patent_app_type] => utility
[patent_app_number] => 13/125443
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 14853
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125443
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125443 | Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester | Oct 20, 2009 | Issued |